BLOGS

Freedom to Operate ensures that your innovation journey remains unhindered by existing intellectual property rights. It provides the legal assurance to commercialize products without infringing on others’ patents.

The North American innovation environment now faces a formidable challenge: unseen adversaries leveraging patents to extract value rather than create it.

As innovation accelerates, the ability to unlock value from intellectual property (IP) is more critical than ever. In 2025, Canadian firms must adapt by adopting forward-thinking strategies to monetize patents, boost licensing revenues, and enhance IP valuation.

In 2024, a U.S.-based biotech company came within inches of a catastrophic $12 million patent infringement lawsuit.

Patent litigation can be a game-changer, especially when a case involves millions or even billions of dollars. With a high-stakes $500M patent litigation case on the line, every detail counts.

Patent search tools are essential in intellectual property for ensuring that new ideas are original and eligible for patenting.

Nexgen Biologics, a California biotech company, had only six weeks to go before they could release their groundbreaking cell preservation technology. Their plans for celebration were short-lived. A routine message from their IP counsel brought the bad news: an initial review had revealed a possible patent infringement problem threatening not just their launch but the existence of the company.

Quantify Freedom To operate costs for Canadian companies to optimize compliance, unlock growth, and gain competitive advantage in the market

Freedom-To-Operate refers to the assurance that a product, service, or process can be developed, marketed, and used in a particular market.

The concept of "Freedom to Operate" is a critical consideration for businesses, particularly in the realms of intellectual property.